Advanced search
Publication Cover
Neuro-Ophthalmology Volume 45, 2021 - Issue 1
Submit an article Journal homepage
100
Views
5
CrossRef citations to date
0
Altmetric
Case Report

Late Onset Macular Oedema in a Patient with Multiple Sclerosis Treated with Fingolimod

Anna Camós-Carrerasa Ophthalmology Department, Hospital Clinic de Barcelona, Barcelona, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1198-4450
ORCID Icon,
Salut Alba-Arbalatb Neurology Department, Hospital Clinic de Barcelona, Barcelona, Spain
,
Marina Dotti-Boadaa Ophthalmology Department, Hospital Clinic de Barcelona, Barcelona, Spain
,
Alba Parrado-Carrilloa Ophthalmology Department, Hospital Clinic de Barcelona, Barcelona, Spain
,
Carolina Bernal-Moralesa Ophthalmology Department, Hospital Clinic de Barcelona, Barcelona, Spain
,
Albert Saizb Neurology Department, Hospital Clinic de Barcelona, Barcelona, Spain
&
Bernardo Sánchez-Dalmaua Ophthalmology Department, Hospital Clinic de Barcelona, Barcelona, Spain
 show all
Pages 61-64 | Received 15 Jun 2020, Accepted 04 Sep 2020, Published online: 06 Oct 2020

References

  • Jain N, Bhatti MT. Fingolimod-associated macular edema: incidence, detection, and management. Neurology. 2012;78(9):672–680. doi:10.1212/WNL.0b013e318248deea.
  • Chun J, Hartung H-P. Mechanism of action of oral fingolimod in MS. Clin Neuropharmacol. 2010;33(2):91–101. doi:10.1097/WNF.0b013e3181cbf825.Mechanism.
  • Moosavi R, Bremner F, Acheson J. Letter to the editor screening for fingolimod associated macular oedema: experience versus guidelines. Open Ophthalmol J. 2014;8(1):73–74. doi:10.2174/1874364101408010073.
  • Zarbin MA, Jampol LM, Jager RD, et al. Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis. Ophthalmology. 2013;120(7):1432–1439. doi:10.1016/j.ophtha.2012.12.040.
  • Chui J, Herkes GK, Chang A. Management of fingolimod-associated macular edema. JAMA Ophthalmol. 2013;131(5):694–696. doi:10.1001/jamaophthalmol.2013.47.
  • Afshar AR, Fernandes JK, Patel RD, et al. Cystoid macular edema associated with fingolimod use for multiple sclerosis. JAMA Ophthalmol. 2013;131(1):103–107. doi:10.3928/01913913-20100318-04.6.
  • Husmann R, Davies JB, Ghannam M, Berry B, Kelkar P. Fingolimod-associated macular edema controlled with nepafenac non-steroidal anti-inflammatory opthalmologic applications. Clin Mol Allergy. 2020;18(1):10–13. doi:10.1186/s12948-020-00119-4.
  • Thoo S, Cugati S, Lee A, Chen C. Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use. Mult Scler J. 2015;21(2):249–251. doi:10.1177/1352458514528759.
  • Goh LY, Kirthi V, Silber E, Harvey JP, Jackson TL. Real-world incidence of fingolimod-associated macular oedema. Mult Scler Relat Disord. 2020;42(March):102125. doi:10.1016/j.msard.2020.102125.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.